Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells

被引:0
|
作者
Guizhen Wang [1 ,2 ]
Qun Zhao [1 ,3 ]
Hui Zhang [4 ]
Fan Liang [1 ,2 ]
Chen Zhang [1 ,2 ]
Jun Wang [5 ]
Zhenyin Chen [1 ,6 ]
Ran Wu [1 ,6 ]
Hong Yu [7 ]
Beibei Sun [1 ]
Hua Guo [1 ]
Ruie Feng [4 ]
Kaifeng Xu [5 ]
Guangbiao Zhou [1 ]
机构
[1] State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
[2] State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences & University of Chinese Academy of Sciences
[3] Hubei University of Medicine
[4] Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
[5] Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences
[6] Guizhou University School of Medicine
[7] School of Chinese Materia Medica, Beijing University of Chinese
关键词
D O I
暂无
中图分类号
R563.1 [肺炎];
学科分类号
摘要
An unexpected observation among the COVID-19 pandemic is that smokers constituted only 1.4% –18.5% of hospitalized adults, calling for an urgent investigation to determine the role of smoking in SARS-CoV-2infection. Here, we show that cigarette smoke extract(CSE) and carcinogen benzo(a)pyrene(BaP) increase ACE2mRNA but trigger ACE2 protein catabolism. BaP induces an aryl hydrocarbon receptor(AhR)-dependent upregulation of the ubiquitin E3 ligase Skp2 for ACE2 ubiquitination. ACE2 in lung tissues of non-smokers is higher than in smokers, consistent with the findings that tobacco carcinogens downregulate ACE2 in mice.Tobacco carcinogens inhibit SARS-CoV-2 spike protein pseudovirions infection of the cells. Given that tobacco smoke accounts for 8 million deaths including 2.1 million cancer deaths annually and Skp2 is an oncoprotein,tobacco use should not be recommended and cessation plan should be prepared for smokers in COVID-19 pandemic.
引用
收藏
页码:252 / 263+333 +333
页数:13
相关论文
共 50 条
  • [41] Fish ACE2 is not susceptible to SARS-CoV-2
    Shi-Zhe Xie
    Mei-Qin Liu
    Ren-Di Jiang
    Hao-Feng Lin
    Wei Zhang
    Bei Li
    Jia Su
    Fei Ke
    Qi-Ya Zhang
    Zheng-Li Shi
    Xing-Lou Yang
    Virologica Sinica, 2022, (01) : 142 - 144
  • [42] Binding of SARS-CoV-2/SARS-CoV spike protein with human ACE2 receptor
    Koirala, Rajendra P.
    Thapa, Bidhya
    Khanal, Shyam P.
    Powrel, Jhulan
    Adhikari, Rajendra P.
    Adhikari, Narayan P.
    JOURNAL OF PHYSICS COMMUNICATIONS, 2021, 5 (03):
  • [43] MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
    Lu, Dongchao
    Chatterjee, Shambhabi
    Xiao, Ke
    Riedel, Isabelle
    Wang, Yibin
    Foo, Roger
    Bar, Christian
    Thum, Thomas
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 148 : 46 - 49
  • [44] ACE2, Much More Than Just a Receptor for SARS-COV-2
    Samavati, Lobelia
    Uhal, Bruce D.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [45] Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
    Glasgow, Anum
    Glasgow, Jeff
    Limonta, Daniel
    Solomon, Paige
    Lui, Irene
    Zhang, Yang
    Nix, Matthew A.
    Rettko, Nicholas J.
    Zha, Shoshana
    Yamin, Rachel
    Kao, Kevin
    Rosenberg, Oren S.
    Ravetch, Jeffrey V.
    Wiita, Arun P.
    Leung, Kevin K.
    Lim, Shion A.
    Zhou, Xin X.
    Hobman, Tom C.
    Kortemme, Tanja
    Wells, James A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (45) : 28046 - 28055
  • [46] Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
    Jinsung Yang
    Simon J. L. Petitjean
    Melanie Koehler
    Qingrong Zhang
    Andra C. Dumitru
    Wenzhang Chen
    Sylvie Derclaye
    Stéphane P. Vincent
    Patrice Soumillion
    David Alsteens
    Nature Communications, 11
  • [47] Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
    Ge, Jiwan
    Wang, Ruoke
    Ju, Bin
    Zhang, Qi
    Sun, Jing
    Chen, Peng
    Zhang, Senyan
    Tian, Yuling
    Shan, Sisi
    Cheng, Lin
    Zhou, Bing
    Song, Shuo
    Zhao, Juanjuan
    Wang, Haiyan
    Shi, Xuanling
    Ding, Qiang
    Liu, Lei
    Zhao, Jincun
    Zhang, Zheng
    Wang, Xinquan
    Zhang, Linqi
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [48] Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
    Suryamohan, Kushal
    Diwanji, Devan
    Stawiski, Eric W.
    Gupta, Ravi
    Miersch, Shane
    Liu, Jiang
    Chen, Chao
    Jiang, Ying-Ping
    Fellouse, Frederic A.
    Sathirapongsasuti, J. Fah
    Albers, Patrick K.
    Deepak, Tanneeru
    Saberianfar, Reza
    Ratan, Aakrosh
    Washburn, Gavin
    Mis, Monika
    Santhosh, Devi
    Somasekar, Sneha
    Hiranjith, G. H.
    Vargas, Derek
    Mohan, Sangeetha
    Phalke, Sameer
    Kuriakose, Boney
    Antony, Aju
    Ustav, Mart, Jr.
    Schuster, Stephan C.
    Sidhu, Sachdev
    Junutula, Jagath R.
    Jura, Natalia
    Seshagiri, Somasekar
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [49] SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors
    Milne, Stephen
    Yang, Chen Xi
    Timens, Wim
    Bosse, Yohan
    Sin, Don D.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (06): : E50 - E51
  • [50] Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium
    Zhang, Haijun
    Rostami, Mahboubeh R.
    Leopold, Philip L.
    Mezey, Jason G.
    O'Beirne, Sarah L.
    Strulovici-Barel, Yael
    Crystal, Ronald G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (02) : 219 - 229